379 related articles for article (PubMed ID: 11494125)
1. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
2. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev AO; Mao C; Uckun FM
Leuk Lymphoma; 2003 Jun; 44(6):1011-8. PubMed ID: 12854903
[TBL] [Abstract][Full Text] [Related]
3. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.
Turner M; Mee PJ; Costello PS; Williams O; Price AA; Duddy LP; Furlong MT; Geahlen RL; Tybulewicz VL
Nature; 1995 Nov; 378(6554):298-302. PubMed ID: 7477352
[TBL] [Abstract][Full Text] [Related]
4. Syk tyrosine kinase required for mouse viability and B-cell development.
Cheng AM; Rowley B; Pao W; Hayday A; Bolen JB; Pawson T
Nature; 1995 Nov; 378(6554):303-6. PubMed ID: 7477353
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM
Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427
[TBL] [Abstract][Full Text] [Related]
6. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
7. ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells.
Guillaume N; Alleaume C; Munfus D; Capiod JC; Touati G; Pautard B; Desablens B; Lefrère JJ; Gouilleux F; Lassoued K; Gouilleux-Gruart V
Haematologica; 2005 Jul; 90(7):899-905. PubMed ID: 15996927
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex.
Law CL; Sidorenko SP; Chandran KA; Draves KE; Chan AC; Weiss A; Edelhoff S; Disteche CM; Clark EA
J Biol Chem; 1994 Apr; 269(16):12310-9. PubMed ID: 8163536
[TBL] [Abstract][Full Text] [Related]
9. ZAP-70 and Syk expression in canine lymphoid cells and preliminary results on leukaemia cases.
Mortarino M; Gelain ME; Gioia G; Ciusani E; Bazzocchi C; Comazzi S
Vet Immunol Immunopathol; 2009 Apr; 128(4):395-401. PubMed ID: 19144411
[TBL] [Abstract][Full Text] [Related]
10. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F
Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia.
Laurenti L; Petlickovski A; Rumi C; Gobessi S; Piccioni P; Tarnani M; Puggioni P; Marietti S; Sica S; Leone G; Efremov DG
Haematologica; 2005 Nov; 90(11):1533-40. PubMed ID: 16266901
[TBL] [Abstract][Full Text] [Related]
13. Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage.
Tokimasa S; Ohta H; Sawada A; Matsuda Y; Kim JY; Nishiguchi S; Hara J; Takihara Y
Exp Hematol; 2001 Jan; 29(1):93-103. PubMed ID: 11164110
[TBL] [Abstract][Full Text] [Related]
14. Polo-like-kinase 1 (PLK1) as a molecular target to overcome SYK-mediated resistance of B-lineage acute lymphoblastic leukaemia cells to oxidative stress.
Uckun FM; Ozer Z; Qazi S; Tuel-Ahlgren L; Mao C
Br J Haematol; 2010 Mar; 148(5):714-25. PubMed ID: 19912216
[TBL] [Abstract][Full Text] [Related]
15. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
16. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.
Chan AC; van Oers NS; Tran A; Turka L; Law CL; Ryan JC; Clark EA; Weiss A
J Immunol; 1994 May; 152(10):4758-66. PubMed ID: 8176201
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the cDNA for the deleted syk kinase homologous to ZAP-70 from human basophilic leukemia cell line (KU812).
Yagi S; Suzuki K; Hasegawa A; Okumura K; Ra C
Biochem Biophys Res Commun; 1994 Apr; 200(1):28-34. PubMed ID: 7513161
[TBL] [Abstract][Full Text] [Related]
19. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
[TBL] [Abstract][Full Text] [Related]
20. Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia.
Wood CM; Goodman PA; Uckun FM
Leuk Lymphoma; 2002 Dec; 43(12):2355-62. PubMed ID: 12613524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
